Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune system desensitization via gradual allergen exposure, also known as allergen immunotherapy or exposure therapy, is a medical approach designed to reduce or eliminate allergic reactions by gradually introducing increasing amounts of an allergen to which a person is sensitive. This process aims to retrain the immune system to become less reactive or non-responsive (tolerant) to the specific allergen over time. It involves controlled antigen presentation over time, leading to changes in antibody profiles and regulatory T cell activity.
Gradual introduction of increasing allergen doses to shift immune response from IgE-mediated allergy to tolerance through changes in antibody profiles and regulatory T cell activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Desensitization via Gradual Allergen Exposure.